CLASS | DRUG/TOX | LP7790-1 |
COMPONENT | LORazepam | LP16176-7 |
PROPERTY | MCnc | LP6827-2 |
TIME_ASPCT | Pt | LP6960-1 |
SYSTEM | Vitr fld | LP7715-8 |
SCALE_TYP | Qn | LP7753-9 |
parent | LORazepam | Vitreous fluid | Drug toxicology | LP391819-2 |
CLASSTYPE | Laboratory class | |
ORDER_OBS | Both | |
EXAMPLE_UNITS | ng/mL | |
EXAMPLE_UCUM_UNITS | ng/mL | |
UNITSREQUIRED | Y |
LONG_COMMON_NAME | en-US | LORazepam [Mass/volume] in Vitreous fluid |
LONG_COMMON_NAME | en-US | LORazepam [Mass/volume] in Vitreous fluid |
SHORTNAME | en-US | LORazepam Vitf-mCnc |
ConsumerName | en-US | LORazepam, Vitreous fluid |
SHORTNAME | es-AR | lorazepam:concentración de masa:punto en el tiempo:líquido vítreo:cuantitativo: |
SHORTNAME | pt-BR | Lorazepam Vitf-mCnc |
LONG_COMMON_NAME | de-DE | Lorazepam [Masse/Volumen] in Glaskörperflüssigkeit |
LONG_COMMON_NAME | fr-FR | Lorazépam [Masse/Volume] Liquide vitrée ; Numérique |
LONG_COMMON_NAME | nl-NL | Lorazepam [massa/volume] in glasachtig vocht |
LONG_COMMON_NAME | es-MX | LORazepam: Líquido vítreo : Punto temporal: Concentración de masa: Cuantitativo: |
LOINC Version: 2.77